NCT00215878View on ClinicalTrials.gov

D-serine for Posttraumatic Stress Disorder Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

D-serine (~2g /day)

Two 6 weeks treatment arms under a cross over design. In one arm adjuvant treatment with experimental medication (D-serine \~2g /day), in the second arm adjuvant treatment with placebo (\~2g /day)

Trial Locations (1)

91351

Ezrat Nashim-Herzog Memorial Hospital, Jerusalem

All Listed Sponsors
lead

Herzog Hospital

OTHER

NCT00215878 - D-serine for Posttraumatic Stress Disorder Treatment | Biotech Hunter | Biotech Hunter